BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19347865)

  • 1. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.
    Cody NA; Shen Z; Ripeau JS; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Mol Carcinog; 2009 Dec; 48(12):1077-92. PubMed ID: 19347865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p.
    Cody NA; Ouellet V; Manderson EN; Quinn MC; Filali-Mouhim A; Tellis P; Zietarska M; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Oncogene; 2007 Jan; 26(4):618-32. PubMed ID: 16909122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
    Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
    Birch AH; Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2008 Jan; 47(1):56-65. PubMed ID: 17620309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
    Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
    Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer.
    Gambaro K; Quinn MC; Wojnarowicz PM; Arcand SL; de Ladurantaye M; Barrès V; Ripeau JS; Killary AM; Davis EC; Lavoie J; Provencher DM; Mes-Masson AM; Chevrette M; Tonin PN
    Mol Oncol; 2013 Jun; 7(3):513-30. PubMed ID: 23415753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
    Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
    Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
    Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
    Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
    Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of a candidate colorectal cancer tumor-suppressor gene to a 900-kilobase region on the short arm of chromosome 8.
    Flanagan JM; Healey S; Young J; Whitehall V; Trott DA; Newbold RF; Chenevix-Trench G
    Genes Chromosomes Cancer; 2004 Jul; 40(3):247-60. PubMed ID: 15139003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
    Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
    Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12.
    Lott ST; Lovell M; Naylor SL; Killary AM
    Cancer Res; 1998 Aug; 58(16):3533-7. PubMed ID: 9721855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer.
    Rimessi P; Gualandi F; Morelli C; Trabanelli C; Wu Q; Possati L; Montesi M; Barrett JC; Barbanti-Brodano G
    Oncogene; 1994 Dec; 9(12):3467-74. PubMed ID: 7970706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
    Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.